Stock CFRXQ CONTRAFECT CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Calendar ContraFect Corporation

Equities

CFRXQ

US2123264093

Market Closed - OTC Markets
Other stock markets
 15:35:19 26/04/2024 BST 		5-day change 1st Jan Change
0.018 USD 0.00% Intraday chart for ContraFect Corporation -16.67% -40.00%
04-26 North American Morning Briefing : Tech Still in -2- DJ
04-19 North American Morning Briefing : Stock Futures -2- DJ

Chart calendar ContraFect Corporation

3b676ce27d339978e20f79c9d7e29.HGkuTBDps_RY-NWKGmZfSZQ0UWKY6re6eJeT2iO-G48.TCQaNkeD3YBqyaK-dzMyHttXHQPSg-bYAtP8oEHdWr1KL1coQr7VlTS2tg~5aab82ff1375b3d771008830b0bdb714

Upcoming events on ContraFect Corporation

09/05/2024 Q1 2024 Earnings Release (Projected)
08/08/2024 Q2 2024 Earnings Release (Projected)

Past events on ContraFect Corporation

20/11/2023 Extraordinary Shareholders Meeting
23/10/2023 14:00 Extraordinary Shareholders Meeting
20/09/2023 20:30 ASM and ESCMID Joint Conference - Poster Number 007
20/09/2023 14:45 ASM and ESCMID Joint Conference - Methodologies on Clinical Development
07/09/2023 19:15 World Anti Microbial Resistance Congress
14/08/2023 13:30 Q2 2023 Earnings Release
21/06/2023 15:00 Maxim Group Virtual Healthcare Conference
17/06/2023 16:00 ASM Microbe Conference - Poster Number:529
17/06/2023 16:00 ASM Microbe Conference - Poster Number:524
16/06/2023 16:00 ASM Microbe Conference - Poster Number:487
16/06/2023 16:00 ASM Microbe Conference - Poster Number:476
16/05/2023 14:00 Annual General Meeting
15/05/2023 13:00 Q1 2023 Earnings Release
17/04/2023 11:00 European Clinical Microbiology & Infectious Diseases Meeting - Abstract ID #05341
17/04/2023 11:00 European Clinical Microbiology & Infectious Diseases Meeting - Abstract Number : 05336
17/04/2023 11:00 European Clinical Microbiology & Infectious Diseases Meeting - Abstract Number : 02033
17/04/2023 11:00 European Clinical Microbiology & Infectious Diseases Meeting - Abstract Number : 05345
15/04/2023 08:30 European Clinical Microbiology & Infectious Diseases Meeting - Abstract Number : 02033
31/03/2023 13:30 Q4 2022 Earnings Release
10/02/2023 14:00 Extraordinary Shareholders Meeting

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-34,1
-29,9
-13.95%		-47,1
-43,8
-7.57%		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-31,1
-30,2
-2.96%		-27,9
-29,1
4.18%		-34,2
-32,4
-5.73%		-47,3
-44,8
-5.42%		-56,9
-63,4
10.27%
-31,3

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-37,7
-51,5
26.79%		-12,8
-10,1
-26.92%		-28,2
-32,8
14.13%		-20,3
-29,0
30.02%		-65,2
-60,8
-7.16%
-23,4

Net income
Million USD		Released
Forecast
Spread 		-37,7
-51,5
26.79%		-12,8
-10,1
-26.92%		-28,2
-32,8
14.13%		-20,3
-28,1
27.74%		-65,2
-60,8
-7.16%
-23,4

EPS
USD		Released
Forecast
Spread 		-400
-542
26.25%		-123
-90,6
-35.98%		-99,2
-122
18.74%		-44,0
-60,8
27.63%		-125
-124
-0.78%
-3,44

Announcement Date14/03/1918/03/2030/03/2124/03/2231/03/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-11,7
-11,0
-6.68%		-14,1
-11,3
-24.51%		-16,0
-11,9
-34.28%		-20,0
-14,2
-41.28%		-14,2
-12,6
-12.54%		-6,70
-13,2
49.22%		-8,86
-6,50
-36.28%		-7,98
-6,70
-19.03%		-6,68
-7,10
5.96%
-7,40

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-5,29
-10,8
51.02%		-4,40
-11,1
60.52%		-20,2
-11,9
-69.39%		-18,1
-14,2
-27.61%		-17,1
-12,6
-35.45%		-9,84
-13,2
25.46%		-1,37
-6,50
78.91%		-7,57
-6,70
-12.96%		-5,36
-7,10
24.52%
-7,40

Net income
Million USD		Released
Forecast
Spread 		-5,29
-10,8
51.02%		-4,40
-10,5
58.03%		-20,2
-11,9
-69.39%		-18,1
-13,0
-39.32%		-17,1
-10,2
-67.32%		-9,84
-13,2
25.46%		-1,37
-6,50
78.91%		-7,57
-6,70
-12.96%		-5,36
-7,10
24.52%
-7,40

EPS
USD		Released
Forecast
Spread 		-10,4
-22,4
53.57%		-8,80
-22,4
60.71%		-40,8
-23,8
-71.43%		-36,8
-26,4
-39.39%		-34,4
-18,4
-86.96%		-16,1
-27,2
40.66%		-0,69
-10,8
93.63%		-1,94
-1,81
-7.18%		-0,50
-0,66
24.24%
-0,69

Announcement Date15/11/2124/03/2216/05/2215/08/2214/11/2231/03/2315/05/2314/08/2314/11/23-

Upcoming sector events for ContraFect Corporation

28/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
28/04/2024 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
28/04/2024 MORPHOSYS AG: Q1 2024 Earnings Release
29/04/2024 21:05 QIAGEN N.V.: Q1 2024 Earnings Release
29/04/2024 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
30/04/2024 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for ContraFect Corporation

Today GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
Today GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 06:00 BB BIOTECH AG: Q1 2024 Earnings Release
25/04/2024 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
25/04/2024 HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
25/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 12:00 MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
25/04/2024 07:00 PURETECH HEALTH PLC: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CFRXQ Stock
  4. Calendar ContraFect Corporation